日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Consensus Guidelines for the Management of Tissue Filler-Induced Vision Loss in the United Kingdom

英国组织填充物引起视力丧失管理共识指南

Sansome, Stafford; Clague, Mike; Convery, Cormac; Davies, Emma; Fairris, Catherine; Goodman, Greg; Harris, Steven; Hawkes, Elizabeth; Hay, Gordon; Murray, Gillian; Shah-Desai, Sabrina; Vize, Colin; Walker, Lee; Neffendorf, James E

Confidence of UK Ophthalmology Registrars in Managing Posterior Capsular Rupture: Results from a National Trainee Survey

英国眼科住院医师对处理后囊破裂的信心:一项全国性住院医师调查的结果

Swampillai, Andrew J; Nowak, Victoria A; Maubon, Laura; Neffendorf, James E; Sahota, Dilraj; Williams, Olayinka; Lakhani, Bansri; Soare, Cristina; Sychev, Ivan; Ridyard, Edward; Patel, Praveen J; Park, Jonathan C

Retinal toxicity secondary to subconjunctival cefuroxime following pars plana vitrectomy: A case report and literature review

玻璃体切除术后结膜下注射头孢呋辛引起的视网膜毒性:病例报告及文献综述

Raharja, Antony; Neffendorf, James E; Williamson, Tom H

Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial

对既往接受过治疗的新生血管性年龄相关性黄斑变性患者进行黄斑前近距离放射治疗24个月疗效和安全性的评估:MERLOT随机临床试验

Jackson, Timothy L; Soare, Cristina; Petrarca, Caroline; Simpson, Andrew; Neffendorf, James E; Petrarca, Robert; Muldrew, Alyson; Peto, Tunde; Chakravarthy, Usha; Membrey, Luke; Haynes, Richard; Costen, Mark; Steel, David; Desai, Riti

Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy

通过时间分辨磷光各向异性测量雷珠单抗、阿柏西普和贝伐单抗的流体动力学半径

Liisa M Hirvonen, Gilbert O Fruhwirth, Nishanthan Srikantha, Matthew J Barber, James E Neffendorf, Klaus Suhling, Timothy L Jackson

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

立体定向放射治疗湿性年龄相关性黄斑变性:当前观点

Neffendorf, James E; Jackson, Timothy L